FR2110314A1 - - Google Patents

Info

Publication number
FR2110314A1
FR2110314A1 FR7135618A FR7135618A FR2110314A1 FR 2110314 A1 FR2110314 A1 FR 2110314A1 FR 7135618 A FR7135618 A FR 7135618A FR 7135618 A FR7135618 A FR 7135618A FR 2110314 A1 FR2110314 A1 FR 2110314A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7135618A
Other versions
FR2110314B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Instituto de Angeli SpA
Original Assignee
Instituto de Angeli SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Instituto de Angeli SpA filed Critical Instituto de Angeli SpA
Publication of FR2110314A1 publication Critical patent/FR2110314A1/fr
Application granted granted Critical
Publication of FR2110314B1 publication Critical patent/FR2110314B1/fr
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1641Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7135618A 1970-10-09 1971-10-04 Expired FR2110314B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4816770A GB1357737A (en) 1970-10-09 1970-10-09 Sustained release pharmaceutical compositions

Publications (2)

Publication Number Publication Date
FR2110314A1 true FR2110314A1 (fr) 1972-06-02
FR2110314B1 FR2110314B1 (fr) 1975-06-06

Family

ID=10447626

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7135618A Expired FR2110314B1 (fr) 1970-10-09 1971-10-04

Country Status (8)

Country Link
US (1) US3853988A (fr)
CA (1) CA974883A (fr)
DE (1) DE2149699A1 (fr)
DK (1) DK129434B (fr)
ES (1) ES395533A1 (fr)
FR (1) FR2110314B1 (fr)
GB (1) GB1357737A (fr)
SE (1) SE382560B (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2653338A1 (fr) * 1989-10-23 1991-04-26 Dow Corning Sa Formulation pour des pansements a liberation prolongee de medicament et son utilisation.
WO1995025545A1 (fr) * 1994-03-18 1995-09-28 Alfred Schmidt Utilisation de dimeticone en tant que systeme vehiculaire et/ou d'apport medicamenteux
US5834004A (en) * 1994-03-18 1998-11-10 Upmeyer; Hans-Juergen Enteral composition comprising dimethicone and a photosensitizer and a method of delivery

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51123814A (en) * 1975-04-22 1976-10-28 Shin Etsu Chem Co Ltd A process for preparing gradually releasable solid medicines
US4167558A (en) 1976-02-13 1979-09-11 Hoffmann-La Roche Inc. Novel sustained release tablet formulations
DE2902414A1 (de) * 1979-01-23 1980-08-07 Hoechst Ag Depotkoerper auf basis silicon- kautschuk sowie verfahren zu seiner herstellung
FR2514261B1 (fr) * 1981-10-08 1986-08-22 Aec Chim Organ Biolog Nouvelle composition pour l'enrobage des aliments et des medicaments et granules ainsi enrobes
DE3508097A1 (de) * 1984-07-21 1986-02-06 Hoechst Ag, 6230 Frankfurt Kombinationspraeparat aus xanthinderivaten und o-acetylsalicylsaeure bzw. deren pharmakologisch vertraeglichen salzen und dessen verwendung
US5965161A (en) * 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
US5855915A (en) * 1995-06-30 1999-01-05 Baylor University Tablets or biologically acceptable implants for long-term antiinflammatory drug release
US20110039807A1 (en) * 2009-08-13 2011-02-17 Kim Hyoung-Chun Anti-parkinsonian compound acetylsalicylic acid maltol ester
EP2875072B1 (fr) 2012-07-17 2017-03-15 Dow Global Technologies LLC Composition comprenant un diluant liquide organique et un éther de cellulose a tres faible viscosite

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2805977A (en) * 1955-01-04 1957-09-10 Smith Kline French Lab Sustained release pharmaceutical preparation
GB971486A (en) * 1960-04-01 1964-09-30 Rech S Pharma Et Scient Therapeutic compositions comprising aspirin and polysiloxanes
US3133863A (en) * 1961-03-10 1964-05-19 Strong Cobb Arner Inc Sustained release therapeutic tablet compositions comprising organic solvent-gelled gums
AU407324B2 (en) * 1962-05-01 1970-10-28 Smith, Kline & French Laboratories Powdered silicone products and processes
US3501571A (en) * 1965-12-06 1970-03-17 Smithkline Corp Novel silicone compositions and method of preparing same
US3518344A (en) * 1967-10-02 1970-06-30 Miles Lab Tableting lubricant

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2653338A1 (fr) * 1989-10-23 1991-04-26 Dow Corning Sa Formulation pour des pansements a liberation prolongee de medicament et son utilisation.
EP0465744A1 (fr) * 1989-10-23 1992-01-15 Dow Corning France S.A. Formulations pour des pansements à libération prolongée de médicaments et leur utilisation
WO1995025545A1 (fr) * 1994-03-18 1995-09-28 Alfred Schmidt Utilisation de dimeticone en tant que systeme vehiculaire et/ou d'apport medicamenteux
US5834004A (en) * 1994-03-18 1998-11-10 Upmeyer; Hans-Juergen Enteral composition comprising dimethicone and a photosensitizer and a method of delivery

Also Published As

Publication number Publication date
ES395533A1 (es) 1974-10-16
DE2149699A1 (de) 1972-04-13
CA974883A (en) 1975-09-23
FR2110314B1 (fr) 1975-06-06
SE382560B (sv) 1976-02-09
DK129434C (fr) 1975-03-10
GB1357737A (en) 1974-06-26
US3853988A (en) 1974-12-10
DK129434B (da) 1974-10-14

Similar Documents

Publication Publication Date Title
AR204384A1 (fr)
DK129434C (fr)
ATA96471A (fr)
AU1146470A (fr)
AU2044470A (fr)
AU2017870A (fr)
AU2085370A (fr)
AU1336970A (fr)
AU1326870A (fr)
AU2130570A (fr)
AR195465A1 (fr)
AU2119370A (fr)
AU1004470A (fr)
AU1918570A (fr)
AU1086670A (fr)
AU1943370A (fr)
AU1969370A (fr)
AU1974970A (fr)
AU1189670A (fr)
AU1879170A (fr)
AU2061170A (fr)
ATA672271A (fr)
AU2112570A (fr)
AU2115870A (fr)
AU1328670A (fr)

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse